GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Tenet Healthcare Corp (NYSE:THC) » Definitions » Debt-to-Equity

Tenet Healthcare (Tenet Healthcare) Debt-to-Equity

: 9.33 (As of Dec. 2023)
View and export this data going back to 1976. Start your Free Trial

Tenet Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $120 Mil. Tenet Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $14,882 Mil. Tenet Healthcare's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $1,608 Mil. Tenet Healthcare's debt to equity for the quarter that ended in Dec. 2023 was 9.33.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Tenet Healthcare's Debt-to-Equity or its related term are showing as below:

THC' s Debt-to-Equity Range Over the Past 10 Years
Min: -124.59   Med: 14.21   Max: 561.39
Current: 9.33

During the past 13 years, the highest Debt-to-Equity Ratio of Tenet Healthcare was 561.39. The lowest was -124.59. And the median was 14.21.

THC's Debt-to-Equity is ranked worse than
98.35% of 544 companies
in the Healthcare Providers & Services industry
Industry Median: 0.47 vs THC: 9.33

Tenet Healthcare Debt-to-Equity Historical Data

The historical data trend for Tenet Healthcare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenet Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -35.37 561.39 15.22 13.20 9.33

Tenet Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.20 12.23 11.21 10.28 9.33

Competitive Comparison

For the Medical Care Facilities subindustry, Tenet Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tenet Healthcare Debt-to-Equity Distribution

For the Healthcare Providers & Services industry and Healthcare sector, Tenet Healthcare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Tenet Healthcare's Debt-to-Equity falls into.



Tenet Healthcare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Tenet Healthcare's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Tenet Healthcare's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tenet Healthcare  (NYSE:THC) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Tenet Healthcare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Tenet Healthcare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenet Healthcare (Tenet Healthcare) Business Description

Traded in Other Exchanges
Address
14201 Dallas Parkway, Dallas, TX, USA, 75254
Tenet Healthcare is a Dallas-based healthcare services organization. It operates a collection of hospitals (about 60 as of June 2023) and over 550 ambulatory surgery centers and other outpatient facilities across the U.S., primarily in the South. Through its Conifer segment, Tenet also provides revenue cycle management solutions.
Executives
Richard W Fisher director
Roy Blunt director 2702 LOVE FIELD DRIVE, HDQ 4GC, DALLAS TX 75235
Paola M Arbour officer: EVP, Chief Information Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Stephen H Rusckowski director C/O QUEST DIAGNOSTICS, 500 PLAZA DRIVE, SECAUCUS NJ 07094
Thomas W Arnst officer: EVP, Chief Admin. Officer & GC 14201 DALLAS PARKWAY, DALLAS TX 75254
Tammy Romo director C/O SOUTHWEST AIRINES CO., 2702 LOVE FIELD DR., DALLAS TX 75235
Daniel J Cancelmi officer: Principal Accounting Officer 13737 NOEL ROAD, SUITE 100, DALLAS TX 75240
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Richard J Mark director 1901 CHOUTEAU AVENUE MC-1310, ST. LOUIS MO 63103
Ronald A Rittenmeyer director 5400 LEGACY DRIVE, PLANO TX 75024
Lisa Y Foo officer: EVP, Commercial Ops 14201 DALLAS PARKWAY, DALLAS TX 75254
Audrey T. Andrews officer: SVP and General Counsel 1445 ROSS AVENUE, SUITE 1400, DALLAS TX 75202
Meghan Fitzgerald director C/O VION PHARMACEUTICALS, INC., 4 SCIENCE PARK, NEW HAVEN CT 06511
Howard Hacker officer: EVP, Chief Compliance Officer 14201 DALLAS PARKWAY, DALLAS TX 75254
Marie Quintana officer: EVP, Marketing/Communications 14201 DALLAS PARKWAY, DALLAS TX 75254